Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms

Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 2000-09, Vol.18 (3), p.287-292
Hauptverfasser: Nakajima, Jun, Takamoto, Shinichi, Oka, Teruaki, Tanaka, Makoto, Takeuchi, Eriho, Murakawa, Tomohiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 3
container_start_page 287
container_title European journal of cardio-thoracic surgery
container_volume 18
creator Nakajima, Jun
Takamoto, Shinichi
Oka, Teruaki
Tanaka, Makoto
Takeuchi, Eriho
Murakawa, Tomohiro
description Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.
doi_str_mv 10.1016/S1010-7940(00)00523-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72232670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S1010-7940(00)00523-6</oup_id><sourcerecordid>72232670</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</originalsourceid><addsrcrecordid>eNptkE9v1DAQxa0K1JbCRyjKASE4GMZ2bCfHqmJpRSWE-KOqF2vWsbWmziaNs4J8exyylCIhj-w5_N688SPklMEbBky9_ZxvoLou4RXAawDJBVUH5JhVWlAtyutHuf-DHJEnKX0HACW4PiRHDGotpNDH5HIVux-FncaudeMQbIFbjFMKqeh8Eae233ShKayLMRVhW4ybqc2Q68O4cTFgLLau6yOmNj0ljz3G5J7t3xPydfXuy_kFvfr4_vL87IpaycqRegWstpWEdcVqLr3VDLnEWlau9I3l6B3ydaW08ojCNUpWlQOZT8lk42pxQl4uc_uhu9u5NJo2pHlBzKvsktGcC640ZFAuoB26lAbnTT-EFofJMDBzhuZ3hmYOyMBcOUOjsu753mC3bl3zQLWEloEXewCTxegH3NqQ_nL5n0rM_rBg3a7_vzX9x5rO1nSRhDS6n_ciHG6N0kJLc3F9Yz7Uq2-a1Tfmk_gFYcKWeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72232670</pqid></control><display><type>article</type><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</creator><creatorcontrib>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</creatorcontrib><description>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/S1010-7940(00)00523-6</identifier><identifier>PMID: 10973537</identifier><identifier>CODEN: EJCSE7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Science B.V</publisher><subject>Adult ; Aged ; Antigens, CD - immunology ; Biological and medical sciences ; Carcinoma - immunology ; Carcinoma - pathology ; Carcinoma - surgery ; CD10 ; CD4-positive lymphocytes ; CD8-positive lymphocytes ; Diagnosis, Differential ; Female ; Flow Cytometry ; Humans ; Lymphocyte Count - methods ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Pneumology ; Retrospective Studies ; T-Lymphocytes - immunology ; T-Lymphocytes - pathology ; Thymectomy ; Thymoma ; Thymoma - immunology ; Thymoma - pathology ; Thymoma - surgery ; Thymus neoplasms ; Thymus Neoplasms - immunology ; Thymus Neoplasms - pathology ; Thymus Neoplasms - surgery ; Tumors of the respiratory system and mediastinum</subject><ispartof>European journal of cardio-thoracic surgery, 2000-09, Vol.18 (3), p.287-292</ispartof><rights>Elsevier Science B.V. © 2000 Elsevier Science B.V. All rights reserved. 2000</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</citedby><cites>FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1514630$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10973537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakajima, Jun</creatorcontrib><creatorcontrib>Takamoto, Shinichi</creatorcontrib><creatorcontrib>Oka, Teruaki</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Takeuchi, Eriho</creatorcontrib><creatorcontrib>Murakawa, Tomohiro</creatorcontrib><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, CD - immunology</subject><subject>Biological and medical sciences</subject><subject>Carcinoma - immunology</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>CD10</subject><subject>CD4-positive lymphocytes</subject><subject>CD8-positive lymphocytes</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Lymphocyte Count - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Pneumology</subject><subject>Retrospective Studies</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - pathology</subject><subject>Thymectomy</subject><subject>Thymoma</subject><subject>Thymoma - immunology</subject><subject>Thymoma - pathology</subject><subject>Thymoma - surgery</subject><subject>Thymus neoplasms</subject><subject>Thymus Neoplasms - immunology</subject><subject>Thymus Neoplasms - pathology</subject><subject>Thymus Neoplasms - surgery</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE9v1DAQxa0K1JbCRyjKASE4GMZ2bCfHqmJpRSWE-KOqF2vWsbWmziaNs4J8exyylCIhj-w5_N688SPklMEbBky9_ZxvoLou4RXAawDJBVUH5JhVWlAtyutHuf-DHJEnKX0HACW4PiRHDGotpNDH5HIVux-FncaudeMQbIFbjFMKqeh8Eae233ShKayLMRVhW4ybqc2Q68O4cTFgLLau6yOmNj0ljz3G5J7t3xPydfXuy_kFvfr4_vL87IpaycqRegWstpWEdcVqLr3VDLnEWlau9I3l6B3ydaW08ojCNUpWlQOZT8lk42pxQl4uc_uhu9u5NJo2pHlBzKvsktGcC640ZFAuoB26lAbnTT-EFofJMDBzhuZ3hmYOyMBcOUOjsu753mC3bl3zQLWEloEXewCTxegH3NqQ_nL5n0rM_rBg3a7_vzX9x5rO1nSRhDS6n_ciHG6N0kJLc3F9Yz7Uq2-a1Tfmk_gFYcKWeA</recordid><startdate>20000901</startdate><enddate>20000901</enddate><creator>Nakajima, Jun</creator><creator>Takamoto, Shinichi</creator><creator>Oka, Teruaki</creator><creator>Tanaka, Makoto</creator><creator>Takeuchi, Eriho</creator><creator>Murakawa, Tomohiro</creator><general>Elsevier Science B.V</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000901</creationdate><title>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</title><author>Nakajima, Jun ; Takamoto, Shinichi ; Oka, Teruaki ; Tanaka, Makoto ; Takeuchi, Eriho ; Murakawa, Tomohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-f6019c850b81925fc71a25a958e4fdc2afea2b8676faa3ed6588e05050415de93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, CD - immunology</topic><topic>Biological and medical sciences</topic><topic>Carcinoma - immunology</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>CD10</topic><topic>CD4-positive lymphocytes</topic><topic>CD8-positive lymphocytes</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Lymphocyte Count - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Pneumology</topic><topic>Retrospective Studies</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - pathology</topic><topic>Thymectomy</topic><topic>Thymoma</topic><topic>Thymoma - immunology</topic><topic>Thymoma - pathology</topic><topic>Thymoma - surgery</topic><topic>Thymus neoplasms</topic><topic>Thymus Neoplasms - immunology</topic><topic>Thymus Neoplasms - pathology</topic><topic>Thymus Neoplasms - surgery</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakajima, Jun</creatorcontrib><creatorcontrib>Takamoto, Shinichi</creatorcontrib><creatorcontrib>Oka, Teruaki</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Takeuchi, Eriho</creatorcontrib><creatorcontrib>Murakawa, Tomohiro</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakajima, Jun</au><au>Takamoto, Shinichi</au><au>Oka, Teruaki</au><au>Tanaka, Makoto</au><au>Takeuchi, Eriho</au><au>Murakawa, Tomohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>2000-09-01</date><risdate>2000</risdate><volume>18</volume><issue>3</issue><spage>287</spage><epage>292</epage><pages>287-292</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><coden>EJCSE7</coden><abstract>Objective: There have been conflicts concerning the criteria for diagnosing malignant epithelial neoplasms of thymic origin. To differentiate thymic carcinomas from thymomas, the maturation stage of T-lineage lymphoid cells infiltrating thymomas and thymic carcinomas was examined by flow cytometry to associate it with the degree of tumor malignancy. Methods: Multidimensional flow cytometric analysis was performed on the lymphoid cells extracted from 27 thymic epithelial neoplasms (14 encapsulated thymomas, ten invasive thymomas, and three thymic carcinomas) by using anti-CD3, -CD4, -CD8, -CD10, -CD20, -CD38, -CD45RA, and -CD45RO monoclonal antibodies. Results: CD4 and CD8 were co-expressed on 76.8% of the lymphoid cells in encapsulated thymoma (n=14), 59.2% in invasive thymoma (n=10), and 6.7% in thymic cancer (n=3). The percentage of CD4- or CD8- single positive cells was 11.4% in encapsulated thymoma, 23.9% in invasive thymoma, and 77.7% in thymic cancer. The percentage of CD10-positive cells was 20.8% in encapsulated thymoma, 13.2% in invasive thymoma, and 6.0% in thymic cancer. The percentage of CD20-positive cell was 2.6% in encapsulated thymoma, 3.3% in invasive thymoma, and 31.6% in thymic cancer. There were significant statistical differences in the percentages of CD4/CD8 double positive cells, CD4- or CD8-single positive cells, CD10-positive cells and CD20-positive cells among the three groups. Two cases classified as invasive thymoma by pathohistological examination, however, showed the infiltration of mature lymphocytes like as thymic cancers. Conclusions: CD4+CD8+ or CD10+ T-lineage cells were the most reliable markers of the benignancy of thymic epithelial tumors. CD4- or CD8-single positive cells or CD20-positive cells were characteristic in thymic carcinoma. Flow cytometry on the maturity of lymphoid cells infiltrating thymic epithelial tumors was feasible for determining their degree of malignancy. Some invasive thymomas showed the intermediate characteristics with thymomatous epithelia and mature lymphoid cells.</abstract><cop>Amsterdam</cop><pub>Elsevier Science B.V</pub><pmid>10973537</pmid><doi>10.1016/S1010-7940(00)00523-6</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1010-7940
ispartof European journal of cardio-thoracic surgery, 2000-09, Vol.18 (3), p.287-292
issn 1010-7940
1873-734X
language eng
recordid cdi_proquest_miscellaneous_72232670
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Antigens, CD - immunology
Biological and medical sciences
Carcinoma - immunology
Carcinoma - pathology
Carcinoma - surgery
CD10
CD4-positive lymphocytes
CD8-positive lymphocytes
Diagnosis, Differential
Female
Flow Cytometry
Humans
Lymphocyte Count - methods
Male
Medical sciences
Middle Aged
Neoplasm Staging
Pneumology
Retrospective Studies
T-Lymphocytes - immunology
T-Lymphocytes - pathology
Thymectomy
Thymoma
Thymoma - immunology
Thymoma - pathology
Thymoma - surgery
Thymus neoplasms
Thymus Neoplasms - immunology
Thymus Neoplasms - pathology
Thymus Neoplasms - surgery
Tumors of the respiratory system and mediastinum
title Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A06%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flow%20cytometric%20analysis%20of%20lymphoid%20cells%20in%20thymic%20epithelial%20neoplasms&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Nakajima,%20Jun&rft.date=2000-09-01&rft.volume=18&rft.issue=3&rft.spage=287&rft.epage=292&rft.pages=287-292&rft.issn=1010-7940&rft.eissn=1873-734X&rft.coden=EJCSE7&rft_id=info:doi/10.1016/S1010-7940(00)00523-6&rft_dat=%3Cproquest_cross%3E72232670%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72232670&rft_id=info:pmid/10973537&rft_oup_id=10.1016/S1010-7940(00)00523-6&rfr_iscdi=true